Oxford Partners with Meridian to Apply IBM PowerAI Vision to Enhance Early Cancer Diagnosis and Treatment Decisions
Oxford Cancer Biomarkers (OCB) was founded in 2012 with the goal to enable early prediction of cancer and advance the accuracy of cancer treatment.